Dr. Robert Todd Middleton, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St, Ste 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-1211 |
Dr. Krystoff J. Godlewski, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 202 N Division St, Plaza 2 Suite 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-6479 |
Dr. James Martin Wagner, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St, Plaza 2 Suite 201, Auburn, WA 98001 Phone: 253-939-1230 |
Dr. Venkatesh R. Kandallu, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 205 10th St Ne, Auburn, WA 98002 Phone: 253-939-1230 |
Dr. Daniel Aaron Wuthrich, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Ste 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-1211 |
Mary L Borgstadt, ARNP Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 735 12th St Se, Auburn, WA 98002 Phone: 253-876-7990 |
Dr. Kevin Yan-ting Zhou, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Ste 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-1211 |
News Archive
Among patients with a family or past history of colorectal cancer, testing between colonoscopies helps detect CRC and advanced tumors that are either missed or develop rapidly, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.
Loyola Medicine is the leading center in Illinois offering a new noninvasive test for heart disease that now is covered by Medicare.
Scientists at Tokyo Institute of Technology found a simple, yet effective, way to improve how synchronization is measured in chaotic systems.
Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.
Many people diagnosed with breast cancers that are small but invasive could benefit from hormone treatment, a new study led by physicians at Roswell Park Comprehensive Cancer Center confirms. Their findings were published today in the journal JAMA Network Open.
› Verified 7 days ago